[Treatment of orthostatic hypotension due to major hypotensive drugs (exception of ganglioplegics). Trial of dihydroergotamine].
D000293:Adolescent; D000328:Adult; D000959:Antihypertensive Agents / Q000009:adverse effects*; D004878:Ergotamine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007024:Hypotension, Orthostatic / Q000139:chemically induced / Q000188:drug therapy*; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D008875:Middle Aged; D010919:Placebos
D000959:Antihypertensive Agents; D010919:Placebos; D008750:Methyldopa; D004878:Ergotamine
Le traitement de l'hypotension orthostatique des hypotenserurs majeurs (ganglioplégiques exclus). Essai de la dihydroergotamine.